Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins. When molecules of a drug ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced the expanded strategic research collaboration with Hokkaido University. This multi-year ...

Scientists at the Stowers Institute for Medical Research, Helmholtz Munich, the Technical University of Munich, and the University of Oxford have developed RegVelo - a new AI framework that ...

Edward Kang’s RetinaMind analyzes patients’ retinal images and accurately diagnoses neurodevelopmental disorders 89 percent ...

From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...

Humans and other animals are constantly required to make decisions under uncertain conditions or while in rapidly changing ...

The hantavirus outbreak linked to infections aboard the MV Hondius, which arrived in the Canary Islands after several ...

AI-driven functional precision medicine could transform cancer care by testing live tumor cells to deliver personalized, ...

New biological intelligence application integrates multi-omics data into continuously evolving health models, marking a shift ...

Frost & Sullivan is pleased to announce that BostonGene has been recognized as the 2026 Global Company of the Year in ...